pone.0220265.g001.tif (1.06 MB)
National and regional prevalence of ESBL phenotypes, levofloxacin- and trimethoprim-sulfamethoxazole-resistant phenotypes among 1831 isolates of E. coli from UTIs in the USA in 2017.
figure
posted on 2019-12-10, 18:24 authored by Ian A. Critchley, Nicole Cotroneo, Michael J. Pucci, Rodrigo MendesESBL = extended spectrum β-lactamase, LEVO-R = levofloxacin-resistant, TMP-SMX-R = trimethoprim-sulfamethoxazole-resistant.